Matthew P. Pando
Amministratore Delegato presso Recognify Life Sciences, Inc.
Posizioni attive di Matthew P. Pando
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Recognify Life Sciences, Inc.
 Recognify Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Recognify Life Sciences, Inc. develops treatments for cognitive impairment associated with schizophrenia. The company is based in Brisbane, CA. The company was founded by Thomas C. Südhof, Matthew P. Pando, Kristen Angela MacFarlane, Gary Walker. Matthew P. Pando has been the CEO since incorporation. | Amministratore Delegato | - | - |
| Fondatore | - | - | |
| Presidente | - | - | |
Boost Neuroscience, Inc.
 Boost Neuroscience, Inc. Miscellaneous Commercial ServicesCommercial Services Boost Neuroscience, Inc. is an American company that focuses on researching and developing therapies for age-related cognitive deficits. The CEO of the company is Matthew P. Pando. | Amministratore Delegato | - | - |
| Direttore Finanziario/CFO | - | - |
Storia della carriera di Matthew P. Pando
Precedenti posizioni note di Matthew P. Pando
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Exonhit
 Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Direttore Tecnico/Scientifico/R&S | 19/07/2010 | 20/12/2012 |
| Corporate Officer/Principal | 19/07/2010 | 19/07/2010 | |
| EUROBIO SCIENTIFIC | Direttore Tecnico/Scientifico/R&S | 01/04/2008 | - |
Formazione di Matthew P. Pando
| The Salk Institute for Biological Studies | Doctorate Degree |
| Colorado State University | Undergraduate Degree |
| University of California San Diego | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Francia | 3 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 2 |
| Chief Executive Officer | 2 |
Settori
| Consumer Services | 4 |
| Health Technology | 3 |
| Commercial Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| EUROBIO SCIENTIFIC | Health Technology |
| Aziende private | 3 |
|---|---|
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Health Technology |
Recognify Life Sciences, Inc.
Recognify Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Recognify Life Sciences, Inc. develops treatments for cognitive impairment associated with schizophrenia. The company is based in Brisbane, CA. The company was founded by Thomas C. Südhof, Matthew P. Pando, Kristen Angela MacFarlane, Gary Walker. Matthew P. Pando has been the CEO since incorporation. | Commercial Services |
Boost Neuroscience, Inc.
Boost Neuroscience, Inc. Miscellaneous Commercial ServicesCommercial Services Boost Neuroscience, Inc. is an American company that focuses on researching and developing therapies for age-related cognitive deficits. The CEO of the company is Matthew P. Pando. | Commercial Services |
- Borsa valori
- Insiders
- Matthew P. Pando
- Esperienza
